Takeda Intentionally Destroyed Evidence Showing it knew about Actos Bladder Cancer Link
A West Virginia jury found on November 17, 2014 that Takeda Pharmaceutical Co. intentionally destroyed documents to prevent bladder cancer victims from being able to prove that its drug Actos caused their injuries. Takeda was ordered to pay $155,000 to a man who developed bladder cancer after using the drug but had been unable to prove that the drug company had failed to warn of the risk because key documents were missing.
Putting Profits First
Actos hit the market in 1999. Since then it has generated more than $16 billion in sales, according to court documents.
Actos users who have developed bladder cancer allege that Takeda knew about the bladder cancer risk before applying for approval of the drug, as a result of animal testing, and that the risk in humans was confirmed by clinical trials in humans in the early 2000’s. Yet, a warning about the bladder cancer risk was not added to the Actos label until 2011.
Destruction of Evidence
As if it weren’t enough that the drug maker failed to warn patients of the bladder cancer risk, so it could continue to reap the profits for the popular diabetes drug, the company went a step further to block the people it hurt from obtaining compensation.
When Actos bladder cancer victims began trying to claim compensation for their injuries they faced a big hurdle. In order to win they needed to prove that Takeda failed to warn of the risk. Takeda destroyed documents that could be used as evidence against it in the lawsuits. The West Virginia jury was not the first to find that Takeda destroyed key evidence.
In June, 2014, a Louisiana federal judge also found that Takeda had intentionally destroyed evidence that would have helped plaintiffs’ case against it.